Genovis AB (FRA:5GV) GF Score: 93/100 (As of Jul. 08, 2026) — 24% Above Median


FRA:5GV Genovis AB FRA:5GV
93 GF Score
Price €1.67
GF Value €2.57
! 3 Warning Signs
View Full Analysis

What is Genovis AB GF Score?

Genovis AB FRA:5GV -5.59% 93 GF Score is 93 as of Jul. 08, 2026, which is 24% above its 10-year median of 75.00. GuruFocus rates FRA:5GV with a GF Score™ of 93/100 and a GF Value™ of €2.57. The stock has 3 warning signs investors should review.

Genovis AB has the GF Score of 93, which implies that the company might have Highest outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 9/10
3. Growth Rank : 10/10
4. GF Value Rank : 8/10
5. Momentum Rank : 4/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Genovis AB might have Highest outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Genovis AB  (FRA:5GV) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Genovis AB GF Score Related Terms

FRA:5GV vs VRTX, REGN, ALNY: GF Score Comparison

For the Biotechnology subindustry, Genovis AB's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genovis AB GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genovis AB's GF Score distribution charts can be found below:

* The bar in red indicates where Genovis AB's GF Score falls into.


FRA:5GV
93GF Score
Genovis AB FRA:5GV
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 93 mean?
Genovis AB (FRA:5GV) has a GF Score of 93 as of Jul. 08, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Genovis AB and its competitors. This is 24% above median its historical median of 75.00. Over the past decade, Genovis AB's GF Score has ranged from 23.00 to 96.00.
Is Genovis AB's GF Score too high?
Genovis AB's current GF Score of 93 is 24% above median its 10-year median of 75.00. Over the past 10 years, this metric has ranged from a low of 23.00 to a high of 96.00. Overall, Genovis AB has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Genovis AB's GF Score compare to VRTX and REGN?
Genovis AB's GF Score of 93 can be compared against companies in the Biotechnology industry. Historically, Genovis AB's own GF Score has ranged from 23.00 to 96.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Genovis AB and its competitors. Genovis AB's current GF Score is 93, which is 24% above median its own 10-year median of 75.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genovis AB stock overvalued right now?
Genovis AB (FRA:5GV) has a current GF Score of 93. The stock's GF Value™ is €2.57, compared to a current price of €1.67 — trading 34.9% below its estimated fair value. The current GF Score is 93, which is 24% above median its 10-year median of 75.00. Genovis AB's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Genovis AB (FRA:5GV), the current GF Score is 93 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genovis AB (FRA:5GV) Overvalued in 2026?

Based on GuruFocus' analysis, Genovis AB stock appears to be undervalued. The current stock price of €1.67 is trading 34.9% below its estimated GF Value™ of €2.57.

Key valuation signals for FRA:5GV:

  • GF Score: 93 (24% above median its 10-year median of 75.00)
  • GF Value™: €2.57 vs. price of €1.67 (34.9% below fair value)
  • GF Score™: 93/100 with 3 warning signs

No single metric tells the full story. See the FRA:5GV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genovis AB Business Description

Other Exchanges GENO:Sweden
Address Kavlinge, Box 4, Lund, SWE, SE-24421
Genovis AB offers customers in the biopharmaceutical and research industries tools that facilitate and save time in the development of new treatment methods and diagnostics. Its enzyme products, known as SmartEnzymes, are used by scientists all over the world, and the product formats facilitate the development and quality control of biological drugs. Its products include Enzyme and Antibodies. Geographically, it operates in Sweden and Rest of the world.
93GF Score

Get the complete analysis for FRA:5GV

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.67
Price
€2.57
GF Value